Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
Clinical trial NCT00056524 · COMPLETED
Trial details
- NCT number
- NCT00056524
- Sponsor
- Avanir Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2007-06-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.